# FDA Inspection 1163046 - Robert Joseph Jeanfreau, MD - February 25, 2022

Source: https://www.keypedia.com/records/fda_inspections/robert-joseph-jeanfreau-md/70e73edb-8f58-4b2c-979e-86c4f2d74f05
Source feed: FDA_Inspections

> FDA Inspection 1163046 for Robert Joseph Jeanfreau, MD on February 25, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1163046
- Company Name: Robert Joseph Jeanfreau, MD
- Inspection Date: 2022-02-25
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 772509 - 2012-02-08](https://www.keypedia.com/records/fda_inspections/robert-joseph-jeanfreau-md/f95fe47b-e89c-40f9-beb7-d52e2a1e1deb)
- [FDA Inspection 557514 - 2009-01-20](https://www.keypedia.com/records/fda_inspections/robert-joseph-jeanfreau-md/721f2bd6-9385-45a4-964d-c1e6c58db4e9)

Company: https://www.keypedia.com/companies/robert-joseph-jeanfreau-md/1cfdd596-afa5-4816-b246-98c355b29492

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c